Home » U.S. Army Targets COVID-19 Vaccine Candidates for Human Trials
U.S. Army Targets COVID-19 Vaccine Candidates for Human Trials
The Walter Reed Army Institute of Research has chosen a lead COVID-19 vaccine candidate from more than two dozen prototypes and plans to begin clinical trials later this year.
The institute plans to begin patient enrollment for a phase 1 trial next month and expects to begin dosing in September, a spokesperson said.
Upcoming Events
-
07May
-
14May
-
30May